5 Most Promising Healthcare Stocks According to Analysts

1. Moderna, Inc. (NASDAQ:MRNA)

Number of Hedge Fund Holders: 52

One-Year Average Price Estimate: $224.50

Moderna, Inc. (NASDAQ:MRNA) ranks 1st in our list of the most promising healthcare stocks to buy according to analysts. Recently, TD Cowen upgraded Moderna, Inc. (NASDAQ:MRNA) to Outperform from Market Perform, citing a favorable catalyst setup ahead.

TD Cowen’s analyst Tyler Van Buren said that Moderna, Inc. (NASDAQ:MRNA)’s expectations for 2023 “are reasonable.”  The analyst believes that given the success of Moderna’s COVID-19 vaccines, it’s likely that the firm would be able to produce successful vaccines for other diseases.

At the end of the fourth quarter of 2022, 52 hedge funds tracked by Insider Monkey reported owning stakes in Moderna, Inc. (NASDAQ:MRNA), up from 44 hedge funds having stakes in the company at the end of the prior quarter. This shows hedge fund sentiment for Moderna, Inc. (NASDAQ:MRNA) is positive.

ClearBridge Select Strategy made the following comment about Moderna, Inc. (NASDAQ:MRNA) in its Q4 2022 investor letter:

“Moderna, Inc. (NASDAQ:MRNA) became a household name during the pandemic as one of the first developers of a COVID-19 vaccine. But the stock sold off sharply as COVID momentum, including high expectations for booster shots, began to wear off, causing investors to slash its fiscal 2023 earnings estimates by two-thirds over the last year. We believe those downward revisions clouded the prospects for the company’s fully funded pipeline of platform opportunities, including cancer, RSV and flu. The cash-rich company also recently expanded its partnership with Merck to improve cancer treatments.”

You can also take a peek at 30 Countries with the Highest GDP in 2022 and 11 Best Debt Free Stocks to Buy.